Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hofer

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2015
Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven yearsDaniel J Lovell, Nicolino Ruperto, Richard Mouy, et al.
Arthritis Research & Therapy|December 28, 2018
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registriesJoost Swart, Gabriella Giancane, Gerd Horneff, et al.
Annals of the Rheumatic Diseases|June 26, 2015
Recommendations for the management of autoinflammatory diseasesNienke M ter Haar, Marlen Oswald, Jerold Jeyaratnam, et al.
Frontiers in Pediatrics|June 14, 2021
Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in SwitzerlandLuregn J Schlapbach, Maya C Andre, Serge Grazioli, et al.
Annals of the Rheumatic Diseases|February 1, 2015
Evidence-based provisional clinical classification criteria for autoinflammatory periodic feversSilvia Federici, Maria Pia Sormani, Seza Ozen, et al.
Pediatric Rheumatology Online Journal|March 16, 2025
African guidelines for diagnosis and management of polyarticular juvenile idiopathic arthritis: PAFLAR initiativeMohammed Hassan Abu-Zaid, Angela Nyangore Migowa, Hanna Lishan Kassa, et al.
The New England Journal of Medicine|May 17, 2018
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever SyndromesFabrizio De Benedetti, Marco Gattorno, Jordi Anton, et al.
Arthritis and Rheumatism|March 2, 2010
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.
The New England Journal of Medicine|December 21, 2012
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritisNicolino Ruperto, Hermine I Brunner, Pierre Quartier, et al.
Arthritis Care & Research|June 29, 2010
The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositisNicolino Ruperto, Angela Pistorio, Angelo Ravelli, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2015
Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven yearsDaniel J Lovell, Nicolino Ruperto, Richard Mouy, et al.
Arthritis Research & Therapy|December 28, 2018
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registriesJoost Swart, Gabriella Giancane, Gerd Horneff, et al.
Annals of the Rheumatic Diseases|June 26, 2015
Recommendations for the management of autoinflammatory diseasesNienke M ter Haar, Marlen Oswald, Jerold Jeyaratnam, et al.
Frontiers in Pediatrics|June 14, 2021
Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in SwitzerlandLuregn J Schlapbach, Maya C Andre, Serge Grazioli, et al.
Annals of the Rheumatic Diseases|February 1, 2015
Evidence-based provisional clinical classification criteria for autoinflammatory periodic feversSilvia Federici, Maria Pia Sormani, Seza Ozen, et al.
Pediatric Rheumatology Online Journal|March 16, 2025
African guidelines for diagnosis and management of polyarticular juvenile idiopathic arthritis: PAFLAR initiativeMohammed Hassan Abu-Zaid, Angela Nyangore Migowa, Hanna Lishan Kassa, et al.
The New England Journal of Medicine|May 17, 2018
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever SyndromesFabrizio De Benedetti, Marco Gattorno, Jordi Anton, et al.
Arthritis and Rheumatism|March 2, 2010
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.
The New England Journal of Medicine|December 21, 2012
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritisNicolino Ruperto, Hermine I Brunner, Pierre Quartier, et al.
Arthritis Care & Research|June 29, 2010
The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositisNicolino Ruperto, Angela Pistorio, Angelo Ravelli, et al.
Pageof 10